Investing in Cures Summit - March 2, 2019

Transcripts and Audio Recordings from the 2019 Investing in Cures Summit, held at The Umstead Hotel & Spa in Cary, North Carolina on March 2, 2019


A note to JAWS users: we recommend ignoring the spoken invitation to open the audio files in Soundcloud (which opens the file in a new tab and results in dueling audio).  Instead, tab until JAWS reads “Play” on each file.

Welcome & Opening Remarks

Inherited Retinal Disease Science Landscape

Brian Mansfield, PhD, Foundation Fighting Blindness

Inherited Retinal Disease Science Updates Panel

Moderated by Stephen Rose, PhD, Foundation Fighting Blindness
• Leah Byrne, PhD, University of Pittsburgh
• Joseph Carroll, PhD, The Medical College of Wisconsin
• Trevor McGill, PhD, Oregon Health & Science University
• Eric Pierce, MD, PhD, Massachusetts Eye & Ear

The Art of Translation Panel

Moderated by Amy Laster, PhD, Foundation Fighting Blindness

Retinal Degeneration Fund Portfolio & Emerging Company Updates

Moderated by Ben Yerxa, PhD, Foundation Fighting Blindness
• HORAMA: Christine Placet
• Mireca: Prof. François Paquet-Durand
• Nacuity Pharmaceuticals: Halden Conner
• Nayan Therapeutics: Milind Desphande, PhD
• ProQR: David Rodman, MD
• SparingVision: Stephen Rose, PhD

Summit Luncheon

featuring keynote speaker
Omid Karkouti, MS
Co-Founder & CEO, Perception Therapeutics

Public Company Forum

Moderated by Rusty Kelley, PhD, MBA • Foundation Fighting Blindness
• AGTC: Sue Washer
• Eloxx Pharmaceuticals, Inc: Robert Ward
• miRagen Therapeutics: William Marshall, PhD
• Nightstar Therapeutics: David Fellows
• Ophthotech: Kourous Rezaei, MD

Public Company Forum Q&A

The Ecosystem Panel

Moderated by Kelly Lisbakken, Wedbush Securities
• John Corneille, JD, Foundation Fighting Blindness
• Mark McClellan, MD, PhD, Duke University
• David Nierengarten, PhD, Wedbush Securities
• Eric Pierce, MD, PhD, Massachusetts Eye & Ear
• Christy Shaffer, PhD, Hatteras Venture Partners
• Kali Stasi, MD, PhD, Novartis
• Sue Washer, AGTC

Closing Remarks

Warren Thaler, MBA
Chairman, RD Fund